Pregled bibliografske jedinice broj: 422579
Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease
Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease // Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33 (2009), 7; 1226-1231 doi:10.1016/j.pnpbp.2009.07.004 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 422579 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease
Autori
Muck-Šeler, Dorotea ; Presečki, Paola ; Mimica, Ninoslav ; Mustapić, Maja ; Pivac, Nela ; Babić, Ana ; Nedić, Gordana ; Folnegović-Šmalc, Vera
Izvornik
Progress in Neuro-Psychopharmacology and Biological Psychiatry (0278-5846) 33
(2009), 7;
1226-1231
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Alzheimer’ s disease; blood platelets; monoamine oxidase type B; phase of
Sažetak
Alzheimer's disease (AD) is a progressive, neurodegenerative disorder with unclear etiology. Cognitive impairment in AD might be associated with altered serotonergic system. The aim of the study was to determine platelet serotonin (5-HT) concentrations and platelet monoamine oxidase type B (MAO-B) activity in patients with different severity of AD. Platelet 5-HT concentrations and MAO-B activity were determined spectrofluorimetrically in 74 female patients with AD (NINCDS- ADRDA, DSM-IV-TR criteria), subdivided according to the Mini Mental State Examination (MMSE) scores in three groups with a) 23 patients in early (MMSE scores 18-24), b) 23 patients in middle (MMSE 17-10), and c) 28 patients in late (MMSE 9-0) phase of AD, and in 49 age-matched healthy women. Platelet 5- HT concentrations and MAO-B activity were similar between all patients with AD and healthy subjects, but were significantly lower in patients in the late phase of AD than in other phases of AD, and in healthy controls. The significant correlations were found between MMSE scores and platelet 5-HT concentrations, MAO-B activity and age. Lower platelet 5-HT concentration and MAO-B activity in the late phase of AD suggested that these markers might indicate severity and/or clinical progress of AD.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982522-2455 - Molekularna podloga i liječenje psihijatrijskih i stresom izazvanih poremećaja (Pivac, Nela, MZOS ) ( CroRIS)
098-0982522-2457 - Farmakogenomika i proteomika serotoninskog i kateholaminskog sustava (Muck-Šeler, Dorotea, MZOS ) ( CroRIS)
108-1081870-2418 - BAP, shizoafektivni poremećaj,shizofrenija:Različite bolesti ili kontinuum? (Folnegović-Šmalc, Vera, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Psihijatrijska bolnica "Sveti Ivan" Zagreb
Profili:
Paola Presečki
(autor)
Vera Folnegović-Šmalc
(autor)
Ninoslav Mimica
(autor)
Ana Babić
(autor)
Gordana Nedić Erjavec
(autor)
Dorotea Muck-Šeler
(autor)
Nela Pivac
(autor)
Maja Mustapić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE